First purchase was late 2011 and I'm not going anywhere. This current manipulation pales in comparison to what we went through during the R/S times - I stomached that while staring a 50%+ loss in the face every day. It's a lot easier watching these games while sitting on a 150%+ gain and knowing that there are numerous positive developments on the horizon for this company, most notably an eventual buy-out. Thanks for all your input over the years Donjay.
Sentiment: Strong Buy
But they have had conference calls in the past where they just discussed things we already knew about (which of course were all positive). I think there was disappointment with the last conference call because many retail shareholders went into it thinking something earth-shattering was going to be revealed. I respectfully suggest that we not speculate going into this call - it's just a business update as far as we know, nothing more, nothing less.
Seems like we have a nice buying opportunity here. Anxiously awaiting news on USDA approval, India approval, South America partnership, commencement of lung cancer trial and possible HER-2 deal.
There seems to be a lot of noise on the MB lately so I thought I would share the following excerpt from an article I read in this month's Sky Magazine entitled "Dispatches from Cancer's Front Lines". The excerpt was based on an interview with Dr. James L. Gulley who is the director of the Medical Oncology Service and head of an immunotherapy clinical group at the Center for Cancer Research (which is part of the NCI): "Gulley says that we are past the point where it is a mystery whether immunotherapy works. It clearly does, just not in everyone. The question now, he says, is how to get the [people who do not respond to immunotherapy] to respond. He is placing his bet on combination therapies."
This is just another example of someone outside of the ADXS team (an impartial, well-respected scientist) validating ADXS' approach to cancer. Hold your shares, ignore the BS on this board and let's wait for the trial results come in. I don't think we will be disappointed.
Sentiment: Strong Buy
Wow, you really have no clue how to calculate the pre-reverse split share price, do you. The only person that has lost $97 million is Dr. Kim chasing a now unnecessary ebola vaccine. Whoops-a-daisy!
PRD has more cash on hand than INO - congratulations!!!
Here we go again. Everyone getting ahead of themselves, assuming some "bombshell" is going to be dropped at ASCO and then when the company presents good data but not bombshell data, folks will freak out and call for DOC's head again. If the presentation had ground-breaking data, they would have been selected for an oral presentation as opposed to a poster presentation - please bear that in mind before we all start screaming "easy double from here" and "this will be in the 30's by EOM." I am happy they got selected for a poster presentation but we shouldn't assume that ASCO will be a major catalyst for the SP. I like China's, Justice's and others' advice - just sit back and let ADXS run its course.